Avricore Health Inc.
Avricore Health Inc. AVCRF Peers
See (AVCRF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVCRF | $0.05 | +11.24% | 4.81M | -4.75 | -$0.01 | N/A |
| LZAGY | $68.49 | +0.99% | 49.41B | 64.61 | $1.06 | +0.19% |
| LZAGF | $694.21 | +1.62% | 48.82B | 65.12 | $10.66 | +0.69% |
| WUXAY | $8.19 | +3.02% | 25.21B | 15.17 | $0.54 | +3.40% |
| WUXIF | $7.34 | N/A | 21.49B | 13.59 | $0.54 | +0.52% |
| BMXMF | $129.73 | +5.86% | 15.30B | 32.11 | $4.04 | +0.71% |
| ERFSF | $64.50 | +2.38% | 11.35B | 27.80 | $2.32 | +1.70% |
| SKHHY | $16.04 | -0.12% | 7.70B | 22.59 | $0.71 | +3.96% |
| SKHCF | $14.80 | N/A | 7.11B | 20.56 | $0.72 | +3.92% |
| DSRLF | $104.69 | -3.95% | 5.64B | 27.19 | $3.85 | +1.23% |
Stock Comparison
AVCRF vs LZAGY Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, LZAGY has a market cap of 49.41B. Regarding current trading prices, AVCRF is priced at $0.05, while LZAGY trades at $68.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas LZAGY's P/E ratio is 64.61. In terms of profitability, AVCRF's ROE is +0.05%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, AVCRF is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs LZAGF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, LZAGF has a market cap of 48.82B. Regarding current trading prices, AVCRF is priced at $0.05, while LZAGF trades at $694.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas LZAGF's P/E ratio is 65.12. In terms of profitability, AVCRF's ROE is +0.05%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, AVCRF is more volatile compared to LZAGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs WUXAY Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, WUXAY has a market cap of 25.21B. Regarding current trading prices, AVCRF is priced at $0.05, while WUXAY trades at $8.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas WUXAY's P/E ratio is 15.17. In terms of profitability, AVCRF's ROE is +0.05%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, AVCRF is more volatile compared to WUXAY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs WUXIF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, WUXIF has a market cap of 21.49B. Regarding current trading prices, AVCRF is priced at $0.05, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, AVCRF's ROE is +0.05%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, AVCRF is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs BMXMF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, BMXMF has a market cap of 15.30B. Regarding current trading prices, AVCRF is priced at $0.05, while BMXMF trades at $129.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas BMXMF's P/E ratio is 32.11. In terms of profitability, AVCRF's ROE is +0.05%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, AVCRF is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ERFSF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ERFSF has a market cap of 11.35B. Regarding current trading prices, AVCRF is priced at $0.05, while ERFSF trades at $64.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ERFSF's P/E ratio is 27.80. In terms of profitability, AVCRF's ROE is +0.05%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, AVCRF is more volatile compared to ERFSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs SKHHY Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, SKHHY has a market cap of 7.70B. Regarding current trading prices, AVCRF is priced at $0.05, while SKHHY trades at $16.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas SKHHY's P/E ratio is 22.59. In terms of profitability, AVCRF's ROE is +0.05%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, AVCRF is more volatile compared to SKHHY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs SKHCF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, SKHCF has a market cap of 7.11B. Regarding current trading prices, AVCRF is priced at $0.05, while SKHCF trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas SKHCF's P/E ratio is 20.56. In terms of profitability, AVCRF's ROE is +0.05%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, AVCRF is more volatile compared to SKHCF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs DSRLF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, DSRLF has a market cap of 5.64B. Regarding current trading prices, AVCRF is priced at $0.05, while DSRLF trades at $104.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas DSRLF's P/E ratio is 27.19. In terms of profitability, AVCRF's ROE is +0.05%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, AVCRF is more volatile compared to DSRLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs HNGZY Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, HNGZY has a market cap of 4.49B. Regarding current trading prices, AVCRF is priced at $0.05, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, AVCRF's ROE is +0.05%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, AVCRF is more volatile compared to HNGZY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs VIMGF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, VIMGF has a market cap of 1.81B. Regarding current trading prices, AVCRF is priced at $0.05, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, AVCRF is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs MRCHF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, MRCHF has a market cap of 962.56M. Regarding current trading prices, AVCRF is priced at $0.05, while MRCHF trades at $16.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas MRCHF's P/E ratio is -99.65. In terms of profitability, AVCRF's ROE is +0.05%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, AVCRF is more volatile compared to MRCHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs IDGXF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, IDGXF has a market cap of 186.02M. Regarding current trading prices, AVCRF is priced at $0.05, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, AVCRF is more volatile compared to IDGXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs AMCY Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, AMCY has a market cap of 171.27M. Regarding current trading prices, AVCRF is priced at $0.05, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas AMCY's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to AMCY's ROE of N/A. Regarding short-term risk, AVCRF is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs EDTXF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, EDTXF has a market cap of 166.65M. Regarding current trading prices, AVCRF is priced at $0.05, while EDTXF trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas EDTXF's P/E ratio is -9.74. In terms of profitability, AVCRF's ROE is +0.05%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, AVCRF is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs NNGRF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, NNGRF has a market cap of 164.30M. Regarding current trading prices, AVCRF is priced at $0.05, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, AVCRF's ROE is +0.05%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, AVCRF is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ATLN Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ATLN has a market cap of 151.78M. Regarding current trading prices, AVCRF is priced at $0.05, while ATLN trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ATLN's P/E ratio is -0.71. In terms of profitability, AVCRF's ROE is +0.05%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, AVCRF is more volatile compared to ATLN. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs CORBF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, CORBF has a market cap of 140.61M. Regarding current trading prices, AVCRF is priced at $0.05, while CORBF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas CORBF's P/E ratio is 3.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, AVCRF is more volatile compared to CORBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs THOXF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, THOXF has a market cap of 130.94M. Regarding current trading prices, AVCRF is priced at $0.05, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas THOXF's P/E ratio is -14.40. In terms of profitability, AVCRF's ROE is +0.05%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, AVCRF is more volatile compared to THOXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs DIUXF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, DIUXF has a market cap of 115.49M. Regarding current trading prices, AVCRF is priced at $0.05, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, AVCRF's ROE is +0.05%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, AVCRF is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ANPCF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ANPCF has a market cap of 99.98M. Regarding current trading prices, AVCRF is priced at $0.05, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, AVCRF's ROE is +0.05%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, AVCRF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs TIHE Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, TIHE has a market cap of 71.85M. Regarding current trading prices, AVCRF is priced at $0.05, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas TIHE's P/E ratio is 0.32. In terms of profitability, AVCRF's ROE is +0.05%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, AVCRF is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs BIOGF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, BIOGF has a market cap of 65.41M. Regarding current trading prices, AVCRF is priced at $0.05, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, AVCRF's ROE is +0.05%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, AVCRF is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs PFGTF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, PFGTF has a market cap of 64.95M. Regarding current trading prices, AVCRF is priced at $0.05, while PFGTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas PFGTF's P/E ratio is -4.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, AVCRF is less volatile compared to PFGTF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs PCNEF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, PCNEF has a market cap of 61.99M. Regarding current trading prices, AVCRF is priced at $0.05, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, AVCRF's ROE is +0.05%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, AVCRF is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs BIOQ Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, BIOQ has a market cap of 40.22M. Regarding current trading prices, AVCRF is priced at $0.05, while BIOQ trades at $45.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas BIOQ's P/E ratio is 15.52. In terms of profitability, AVCRF's ROE is +0.05%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, AVCRF is more volatile compared to BIOQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs CLIFF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, CLIFF has a market cap of 29.65M. Regarding current trading prices, AVCRF is priced at $0.05, while CLIFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas CLIFF's P/E ratio is -1.93. In terms of profitability, AVCRF's ROE is +0.05%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, AVCRF is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs SNANF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, SNANF has a market cap of 27.61M. Regarding current trading prices, AVCRF is priced at $0.05, while SNANF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas SNANF's P/E ratio is -12.74. In terms of profitability, AVCRF's ROE is +0.05%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, AVCRF is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ANPCY Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ANPCY has a market cap of 27.08M. Regarding current trading prices, AVCRF is priced at $0.05, while ANPCY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ANPCY's P/E ratio is -0.93. In terms of profitability, AVCRF's ROE is +0.05%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, AVCRF is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs IMMVF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, IMMVF has a market cap of 22.60M. Regarding current trading prices, AVCRF is priced at $0.05, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, AVCRF's ROE is +0.05%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, AVCRF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs VILGF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, VILGF has a market cap of 20.67M. Regarding current trading prices, AVCRF is priced at $0.05, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas VILGF's P/E ratio is -0.30. In terms of profitability, AVCRF's ROE is +0.05%, compared to VILGF's ROE of N/A. Regarding short-term risk, AVCRF is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs PCHM Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, PCHM has a market cap of 20.19M. Regarding current trading prices, AVCRF is priced at $0.05, while PCHM trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas PCHM's P/E ratio is -0.02. In terms of profitability, AVCRF's ROE is +0.05%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, AVCRF is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs LDXHF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, LDXHF has a market cap of 18.71M. Regarding current trading prices, AVCRF is priced at $0.05, while LDXHF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas LDXHF's P/E ratio is -2.50. In terms of profitability, AVCRF's ROE is +0.05%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, AVCRF is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs BMKDF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, BMKDF has a market cap of 17.26M. Regarding current trading prices, AVCRF is priced at $0.05, while BMKDF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas BMKDF's P/E ratio is -18.99. In terms of profitability, AVCRF's ROE is +0.05%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, AVCRF is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs PMSNF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, PMSNF has a market cap of 14.76M. Regarding current trading prices, AVCRF is priced at $0.05, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, AVCRF's ROE is +0.05%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, AVCRF is more volatile compared to PMSNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ABDXF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ABDXF has a market cap of 13.55M. Regarding current trading prices, AVCRF is priced at $0.05, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, AVCRF's ROE is +0.05%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, AVCRF is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs IZOZF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, IZOZF has a market cap of 11.02M. Regarding current trading prices, AVCRF is priced at $0.05, while IZOZF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas IZOZF's P/E ratio is -6.07. In terms of profitability, AVCRF's ROE is +0.05%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, AVCRF is more volatile compared to IZOZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs MXDHF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, MXDHF has a market cap of 8.65M. Regarding current trading prices, AVCRF is priced at $0.05, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, AVCRF's ROE is +0.05%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, AVCRF is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs VRCDF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, VRCDF has a market cap of 7.28M. Regarding current trading prices, AVCRF is priced at $0.05, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, AVCRF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs TDSGF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, TDSGF has a market cap of 6.49M. Regarding current trading prices, AVCRF is priced at $0.05, while TDSGF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas TDSGF's P/E ratio is -2.17. In terms of profitability, AVCRF's ROE is +0.05%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, AVCRF is more volatile compared to TDSGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs GNTLF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, GNTLF has a market cap of 6.07M. Regarding current trading prices, AVCRF is priced at $0.05, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, AVCRF's ROE is +0.05%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, AVCRF is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs SQIDF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, SQIDF has a market cap of 6.07M. Regarding current trading prices, AVCRF is priced at $0.05, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, AVCRF's ROE is +0.05%, compared to SQIDF's ROE of +0.00%. Regarding short-term risk, AVCRF is more volatile compared to SQIDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs SLDX Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, SLDX has a market cap of 4.78M. Regarding current trading prices, AVCRF is priced at $0.05, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas SLDX's P/E ratio is -0.01. In terms of profitability, AVCRF's ROE is +0.05%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, AVCRF is more volatile compared to SLDX. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs RNVA Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, RNVA has a market cap of 4.31M. Regarding current trading prices, AVCRF is priced at $0.05, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas RNVA's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, AVCRF is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs JMPHF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, JMPHF has a market cap of 4.14M. Regarding current trading prices, AVCRF is priced at $0.05, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, AVCRF's ROE is +0.05%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, AVCRF is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs IDXG Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, IDXG has a market cap of 3.96M. Regarding current trading prices, AVCRF is priced at $0.05, while IDXG trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas IDXG's P/E ratio is 3.20. In terms of profitability, AVCRF's ROE is +0.05%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, AVCRF is more volatile compared to IDXG. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs SZLSF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, SZLSF has a market cap of 3.54M. Regarding current trading prices, AVCRF is priced at $0.05, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, AVCRF's ROE is +0.05%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, AVCRF is more volatile compared to SZLSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ICBU Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ICBU has a market cap of 2.87M. Regarding current trading prices, AVCRF is priced at $0.05, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ICBU's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, AVCRF is more volatile compared to ICBU. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs IDTA Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, IDTA has a market cap of 2.02M. Regarding current trading prices, AVCRF is priced at $0.05, while IDTA trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas IDTA's P/E ratio is 5.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, AVCRF is more volatile compared to IDTA. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs IBXXF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, IBXXF has a market cap of 1.61M. Regarding current trading prices, AVCRF is priced at $0.05, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, AVCRF's ROE is +0.05%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, AVCRF is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs IVRO Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, IVRO has a market cap of 1.37M. Regarding current trading prices, AVCRF is priced at $0.05, while IVRO trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas IVRO's P/E ratio is -0.86. In terms of profitability, AVCRF's ROE is +0.05%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, AVCRF is more volatile compared to IVRO. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs DIGP Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, DIGP has a market cap of 1.09M. Regarding current trading prices, AVCRF is priced at $0.05, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas DIGP's P/E ratio is -1.04. In terms of profitability, AVCRF's ROE is +0.05%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, AVCRF is more volatile compared to DIGP. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs SCRSF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, SCRSF has a market cap of 847776.00. Regarding current trading prices, AVCRF is priced at $0.05, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, AVCRF's ROE is +0.05%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, AVCRF is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs RSHN Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, RSHN has a market cap of 817464.00. Regarding current trading prices, AVCRF is priced at $0.05, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas RSHN's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, AVCRF is more volatile compared to RSHN. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs EPGNF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, EPGNF has a market cap of 692790.00. Regarding current trading prices, AVCRF is priced at $0.05, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, AVCRF's ROE is +0.05%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, AVCRF is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs NSTM Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, NSTM has a market cap of 468815.00. Regarding current trading prices, AVCRF is priced at $0.05, while NSTM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas NSTM's P/E ratio is -0.14. In terms of profitability, AVCRF's ROE is +0.05%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, AVCRF is more volatile compared to NSTM. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs MBGNF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, MBGNF has a market cap of 172578.00. Regarding current trading prices, AVCRF is priced at $0.05, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, AVCRF is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs NVTAQ Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, NVTAQ has a market cap of 85948.00. Regarding current trading prices, AVCRF is priced at $0.05, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to NVTAQ's ROE of +1.79%. Regarding short-term risk, AVCRF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ARYC Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ARYC has a market cap of 79348.00. Regarding current trading prices, AVCRF is priced at $0.05, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ARYC's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, AVCRF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs HCLC Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, HCLC has a market cap of 73985.00. Regarding current trading prices, AVCRF is priced at $0.05, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas HCLC's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, AVCRF is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs MEDVF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, MEDVF has a market cap of 54038.00. Regarding current trading prices, AVCRF is priced at $0.05, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, AVCRF's ROE is +0.05%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, AVCRF is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs CHHL Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, CHHL has a market cap of 37320.00. Regarding current trading prices, AVCRF is priced at $0.05, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas CHHL's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to CHHL's ROE of N/A. Regarding short-term risk, AVCRF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs IHTI Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, IHTI has a market cap of 32514.00. Regarding current trading prices, AVCRF is priced at $0.05, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas IHTI's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, AVCRF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs MEDD Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, MEDD has a market cap of 31910.00. Regarding current trading prices, AVCRF is priced at $0.05, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas MEDD's P/E ratio is -0.01. In terms of profitability, AVCRF's ROE is +0.05%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, AVCRF is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs CGNH Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, CGNH has a market cap of 24000.00. Regarding current trading prices, AVCRF is priced at $0.05, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas CGNH's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, AVCRF is less volatile compared to CGNH. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs TOMDF Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, TOMDF has a market cap of 14081.00. Regarding current trading prices, AVCRF is priced at $0.05, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas TOMDF's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, AVCRF is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ABMC Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ABMC has a market cap of 4810.00. Regarding current trading prices, AVCRF is priced at $0.05, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ABMC's P/E ratio is 0.01. In terms of profitability, AVCRF's ROE is +0.05%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, AVCRF is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs RGDXQ Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, RGDXQ has a market cap of 3880.00. Regarding current trading prices, AVCRF is priced at $0.05, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, AVCRF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs DMTKQ Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, DMTKQ has a market cap of 3525.00. Regarding current trading prices, AVCRF is priced at $0.05, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, AVCRF is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs GWHP Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, GWHP has a market cap of 1313.00. Regarding current trading prices, AVCRF is priced at $0.05, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas GWHP's P/E ratio is -0.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, AVCRF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs CYPS Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, CYPS has a market cap of 811.00. Regarding current trading prices, AVCRF is priced at $0.05, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas CYPS's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to CYPS's ROE of N/A. Regarding short-term risk, AVCRF is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs ROSGQ Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, ROSGQ has a market cap of 593.00. Regarding current trading prices, AVCRF is priced at $0.05, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to ROSGQ's ROE of N/A. Regarding short-term risk, AVCRF is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs BIOCQ Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, BIOCQ has a market cap of 263.00. Regarding current trading prices, AVCRF is priced at $0.05, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, AVCRF's ROE is +0.05%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, AVCRF is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs HTGMQ Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, HTGMQ has a market cap of 221.00. Regarding current trading prices, AVCRF is priced at $0.05, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, AVCRF is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.
AVCRF vs OPGX Comparison
AVCRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVCRF stands at 4.81M. In comparison, OPGX has a market cap of 17.00. Regarding current trading prices, AVCRF is priced at $0.05, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVCRF currently has a P/E ratio of -4.75, whereas OPGX's P/E ratio is N/A. In terms of profitability, AVCRF's ROE is +0.05%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, AVCRF is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for AVCRF.